Fidelity Investments’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,319
| Closed | -$36K | – | 5746 |
|
|
2022
Q1 | $36K | Buy |
1,319
+1,252
| +1,869% | +$34.3K | ﹤0.01% | 3802 |
|
|
2021
Q4 | $2K | Buy |
+67
| New | +$1.82K | ﹤0.01% | 4077 |
|
|
2021
Q3 | – | Sell |
-3,480,000
| Closed | -$59.5M | – | 5314 |
|
|
2021
Q2 | $59.5M | Buy |
3,480,000
+721,649
| +26% | +$13.5M | ﹤0.01% | 1353 |
|
|
2021
Q1 | $57.6M | Sell |
2,758,351
-201,649
| -7% | -$4.65M | ﹤0.01% | 1329 |
|
|
2020
Q4 | $67.8M | Buy |
2,960,000
+190,000
| +7% | +$3.62M | 0.01% | 1201 |
|
|
2020
Q3 | $45.2M | Buy |
2,770,000
+1,100,000
| +66% | +$19.9M | ﹤0.01% | 1233 |
|
|
2020
Q2 | $22.6M | Buy |
1,670,000
+89,037
| +6% | +$1.04M | ﹤0.01% | 1492 |
|
|
2020
Q1 | $18.7M | Buy |
1,580,963
+1,580,961
| +79,048,050% | +$35.1M | ﹤0.01% | 1432 |
|
|
2019
Q4 | $0 | Sell |
2
-2
| -50% | -$41 | ﹤0.01% | 4414 |
|
|
2019
Q3 | $0 | Sell |
4
-651,498
| -100% | -$11.9M | ﹤0.01% | 4369 |
|
|
2019
Q2 | $14.8M | Buy |
651,502
+19,051
| +3% | +$514K | ﹤0.01% | 1741 |
|
|
2019
Q1 | $20.3M | Buy |
632,451
+600,246
| +1,864% | +$18.6M | ﹤0.01% | 1604 |
|
|
2018
Q4 | $908K | Sell |
32,205
-59,668
| -65% | -$1.75M | ﹤0.01% | 2410 |
|
|
2018
Q3 | $2.64M | Sell |
91,873
-976,407
| -91% | -$29.3M | ﹤0.01% | 2313 |
|
|
2018
Q2 | $40M | Buy |
1,068,280
+272,880
| +34% | +$10.7M | ﹤0.01% | 1394 |
|
|
2018
Q1 | $31.3M | Sell |
795,400
-508,636
| -39% | -$18.6M | ﹤0.01% | 1511 |
|
|
2017
Q4 | $42.3M | Sell |
1,304,036
-1,119,590
| -46% | -$33.6M | 0.01% | 1377 |
|
|
2017
Q3 | $75.5M | Buy |
2,423,626
+940,717
| +63% | +$27.8M | 0.01% | 1106 |
|
|
2017
Q2 | $41.4M | Buy |
1,482,909
+1,056,389
| +248% | +$23.9M | 0.01% | 1369 |
|
|
2017
Q1 | $7.32M | Buy |
426,520
+306,520
| +255% | +$4.29M | ﹤0.01% | 2069 |
|
|
2016
Q4 | $1.45M | Buy |
+120,000
| New | +$1.55M | ﹤0.01% | 2415 |
|
Fidelity Investments's XENT Position: Q2 2022 in Review
Fidelity Investments sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 1,319 shares — an estimated $36K sold.
Fidelity Investments first reported a position in XENT in Q4 2016 and held it in 21 quarters. The position peaked at $75.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Fidelity Investments reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Fidelity Investments sold 1,319 Intersect ENT, Inc shares in Q2 2022, an estimated $36K.
- Fidelity Investments first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 21 quarters.
- Fidelity Investments's Intersect ENT, Inc position peaked at $75.5M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.